journal cover

Tuberculosis vaccines: Opportunities and challenges

Respirology : Official Journal of the Asian Pacific Society of Respirology

Jan 18, 2018

Bingdong ZhuYing Zhang

Abstract

Tuberculosis (TB) is a serious disease around the world. Bacillus Calmette-Guérin (BCG) is the only TB vaccine licensed for use in human beings, and is effective in protecting infants and children against severe miliary and meningeal TB. However, BCG's protective efficacy is variable in...read more

Mentioned in this Paper

Biological Markers
Vaccines, Inactivated
Study
Immune Response
IFNG
Tuberculosis Vaccines
Vaccines, Attenuated
Tuberculosis
Immunologic Adjuvants
Vaccines
10
1
1
66
1
Paper Details
References
  • References83
  • Citations8
12345...

Similar Papers Found In These Feeds

Memory T Cells

Tuberculosis

Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. Discover the latest research on tuberculosis here.

Cd8 T Memory Cells

DNA Vaccine Delivery: Particulates

Bomaterial-based delivery systems based on micro- and nanoparticles that encapsulate plasmid DNA represent the most promising strategy for DNA vaccine delivery. Microparticulate delivery systems allow for passive targeting to antigen presenting cells through size exclusion and can allow for sustained presentation of DNA to cells through degradation and release of encapsulated vaccines. In contrast, nanoparticle encapsulation leads to increased internalization, overall greater transfection efficiency, and the ability to increase uptake across mucosal surfaces. Discover the latest research on DNA vaccine delivery here

Immunomodulating Agents

Immunomodulating agents are substances that stimulate or suppresse the immune system and may help the body combat againsts cancer, infection, or other diseases. Discover the latest research on immunomodulating agents here.

Initial Mycobacterium Tuberculosis Infection

Interferon Signalling

Via interaction with their specific receptors, interferons (IFNs) activate signal transducer and activator of transcription (STAT) complexes. STAT activation initiates the classical Janus kinase-STAT (JAK-STAT) signaling pathway. In this pathway, JAKs associate with IFN receptors and, following receptor engagement with IFN, phosphorylate both STAT1 and STAT2. As a result, an IFN-stimulated gene factor 3 (ISGF3) complex forms—this contains STAT1, STAT2 and a third transcription factor called IRF9—and moves into the cell nucleus. Inside the nucleus, the ISGF3 complex binds to specific nucleotide sequences called IFN-stimulated response elements (ISREs) in the promoters of certain genes, known as IFN stimulated genes. Discover the latest research on interferon signalling here.

Dna Vaccines

Mycobacterium Tuberculosis Infection

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

© 2020 Meta ULC. All rights reserved

Tuberculosis vaccines: Opportunities and challenges

Respirology : Official Journal of the Asian Pacific Society of Respirology

Jan 18, 2018

Bingdong ZhuYing Zhang

PMID: 29341430

DOI: 10.1111/resp.13245

Abstract

Tuberculosis (TB) is a serious disease around the world. Bacillus Calmette-Guérin (BCG) is the only TB vaccine licensed for use in human beings, and is effective in protecting infants and children against severe miliary and meningeal TB. However, BCG's protective efficacy is variable in...read more

Mentioned in this Paper

Biological Markers
Vaccines, Inactivated
Study
Immune Response
IFNG
Tuberculosis Vaccines
Vaccines, Attenuated
Tuberculosis
Immunologic Adjuvants
Vaccines
10
1
1
66
1

Similar Papers Found In These Feeds

Related Papers

Paper Details
References
  • References83
  • Citations8
12345...
/papers/tuberculosis-vaccines-opportunities-and/29341430